Survival Study of Tumor-Bearing Mice Treated with Rhodium(II) Amidate
Author Information
Author(s): Breno Pannia EspSsito, Szulim Ber Zyngier, Renato Najjar, Roberto Pinto Paes, Suely M. Ykko Ueda, Jos6 Carlos A. Barros
Primary Institution: University of São Paulo
Hypothesis
The study investigates the survival rate of tumor-bearing mice treated with a specific rhodium(II) complex.
Conclusion
The treatment with the rhodium(II) complex allowed for a 90% survival rate in tumor-bearing mice.
Supporting Evidence
- The survival rate of 90% was achieved with the rhodium(II) complex.
- Histopathological alterations were observed in various tissues of treated mice.
- The Survgo dose was determined to be 3.8x10.5 mol/kg.
Takeaway
Researchers gave a special medicine to sick mice and found that most of them lived longer.
Methodology
The study involved treating Balb-c mice with a rhodium(II) complex and assessing survival and histopathological changes.
Limitations
The study only included a small number of mice and focused on specific histopathological alterations.
Participant Demographics
Male Balb-c mice were used in the study.
Want to read the original?
Access the complete publication on the publisher's website